Nicholas A. Ghaphery, D.O., as Personal Representative of the Estate of Austin Ghaphery v. Wheeling Treatment Center, LLC and John Schultz, M.D.

CourtIntermediate Court of Appeals of West Virginia
DecidedNovember 16, 2023
Docket22-ica-150
StatusPublished

This text of Nicholas A. Ghaphery, D.O., as Personal Representative of the Estate of Austin Ghaphery v. Wheeling Treatment Center, LLC and John Schultz, M.D. (Nicholas A. Ghaphery, D.O., as Personal Representative of the Estate of Austin Ghaphery v. Wheeling Treatment Center, LLC and John Schultz, M.D.) is published on Counsel Stack Legal Research, covering Intermediate Court of Appeals of West Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nicholas A. Ghaphery, D.O., as Personal Representative of the Estate of Austin Ghaphery v. Wheeling Treatment Center, LLC and John Schultz, M.D., (W. Va. Ct. App. 2023).

Opinion

IN THE INTERMEDIATE COURT OF APPEALS OF WEST VIRGINIA

FILED NICHOLAS A. GHAPHERY, D.O., November 16, 2023 as Personal Representative of the ESTATE EDYTHE NASH GAISER, CLERK OF AUSTIN GHAPHERY INTERMEDIATE COURT OF APPEALS Plaintiff Below, Petitioner OF WEST VIRGINIA

vs.) No. 22-ICA-150 (Cir. Ct. Ohio Cnty. No. CC-35-2019-C-182)

WHEELING TREATMENT CENTER, LLC, and JOHN SCHULTZ, M.D., Defendants Below, Respondents

MEMORANDUM DECISION

Petitioner, Nicholas A. Ghaphery, D.O. in his capacity as the administrator and personal representative of the estate of Austin Nickalus Ghaphery, his deceased son, appeals the Circuit Court of Ohio County’s September 21, 2022, order granting summary judgment in favor of Respondents, Wheeling Treatment Center, LLC (“WTC”) and its Medical Director John Schultz, M.D. (“Medical Director”). 1 The circuit court found that Austin was not a “patient” pursuant to the Medical Professional Liability Act (“MPLA”), and therefore, WTC and its Medical Director did not owe a duty of care towards Austin when he was denied acceptance into the special purpose medication assisted treatment program on September 28, 2017.

This Court has jurisdiction over this appeal pursuant to West Virginia Code § 51- 11-4 (2022). After considering the parties’ written and oral arguments, the record on appeal, and the applicable law, this Court finds no substantial question of law and no abuse of discretion. For these reasons, a memorandum decision affirming the circuit court’s order is appropriate under Rule 21 of the Rules of Appellate Procedure.

This is a medical negligence action brought by a personal representative of an estate for his deceased son, Austin, alleging that WTC and its Medical Director failed to meet the required standards of care relating to Austin’s pre-admission initial assessment and suicide risk evaluation. The personal representative further alleges that, as a result of WTC’s and the Medical Director’s failure to meet the appropriate standards of care, they proximately caused the death of Austin on November 3, 2017.

1 Petitioner is represented by Patrick S. Cassidy, Esq. Respondents are represented by Rita Massie Biser, Esq. and Lynnette Simon Marshall, Esq. 1 WTC operates a medication assisted treatment program governed by the Medication-Assisted Treatment Program Licensing Act. See W. Va. Code § 16-5Y-1 et seq.; W. Va. Code R. § 69-11-1 et seq. In accordance with the Act, WTC provides medication, combined with counseling, to treat individuals recovering from opioid addiction. WTC only treats opioid addiction in connection with recovery; it is not a crisis stabilization facility, an inpatient psychiatric facility, or a comprehensive mental health center.

In the months before Austin’s presentation at the WTC, he was showing signs of drug abuse. On July 13, 2017, Austin was found in a disoriented and later unresponsive state at his girlfriend’s apartment. Law enforcement and emergency medical technicians were called to the scene and determined that Austin was under the influence of opioid medications. 2 At the request of his parents, Austin began treatment with a primary care physician, John Schmitt, M.D., on July 18, 2017. According to Dr. Schmitt’s treatment notes, Austin denied a drug problem when he was examined. However, in Dr. Schmitt’s deposition, he testified that Austin’s mother discussed with Dr. Schmitt the possibility that Austin should be drug tested. Dr. Schmitt testified that Austin declined a drug test.

Austin was seen a second time by Dr. Schmitt on September 21, 2017. According to Dr. Schmitt’s treatment note, Austin admitted to depression, anxiety, mood swings and suicidal ideations. Austin denied an active plan to commit suicide, and the treatment note states that Austin previously discussed suicidal ideations with his parents, and that all firearms were removed from the house. Dr. Schmitt’s treatment note states Austin agreed that if his psychiatric condition deteriorated, Austin would tell his parents or contact a crisis unit. Dr. Schmitt was considering a referral for Austin to see a psychiatrist if Austin’s condition did not improve. Austin was prescribed anti-anxiety medication for depression and a prescription medication for attention deficit disorder. Austin denied using street drugs or non-prescribed medications.

Dr. Ghaphery’s deposition testimony indicates that sometime in September of 2017, Austin admitted to him that he had a drug problem and asked for help. Dr. Ghaphery investigated drug treatment facilities in the area and contacted WTC to arrange an appointment for Austin. Dr. Ghaphery testified that he did not know what drugs Austin was using, and he did not know that WTC only treated opioid addiction. Nevertheless, an appointment was made for Austin to undergo a pre-admission initial assessment at WTC on September 28, 2017. Dr. Ghaphery took Austin to the appointment and testified that he did not believe Austin was a suicide risk when he left him at WTC for the assessment.

2 A “Call Summary Report” dated July 13, 2017, from the Glen Dale Police Department states that Austin was found in a similar condition on two previous occasions after November of 2016. The parties do not identify whether Austin was transported to a medical facility on July 13, 2017.

2 Austin appeared at WTC for an initial pre-admission assessment, where he underwent a drug screening that was positive for THC and amphetamines. 3 Austin was interviewed by a counselor named Jamie Coen-Pickens and the Medical Director. Ms. Coen-Pickens summarized Austin’s assessment in a “Case Note” dated September 28, 2017, which included a summary of the admission screening. The notes confirmed that Austin was not in withdrawal and did not meet the criteria to enroll in the program. He also met with a counselor and the medical director and disclosed he was taking prescription anti-anxiety medicine and agreed to follow up with his doctor the following week.

Ms. Coen-Pickens testified in her deposition that Austin said he previously used illicit drugs, but that he did not have a “current problem,” and that he only went to WTC at the request of his parents. According to Ms. Coen-Pickens, Austin was not showing signs of withdrawal, he did not disclose any opioid use, and his drug screen was negative for opioids. Based upon these observations, Ms. Coen-Pickens determined that Austin did not meet the criteria for admission to the medication assisted treatment program operated by WTC.

Ms. Coen-Pickens also testified that Austin admitted to prior suicidal ideations with a plan to use a gun, even though he was not actively suicidal on September 28, 2017. Ms. Coen-Pickens testified that she reported Austin’s suicidal ideations to the Medical Director who interviewed Austin. Ms. Coen-Pickens stated that she was present during The Medical Director’s and Austin’s meeting, and that at the conclusion of the meeting, Austin left the facility because he was not accepted into the program. According to Ms. Coen-Pickens, no efforts were made to refer Austin for inpatient psychiatric treatment because he was prescribed medications by Dr. Schmitt, and Austin agreed to keep his appointment with Dr. Schmitt the following week. Ms. Coen-Pickens did not complete a standard “Patient Screening Form” or a Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (“DSM-V”), Substance Use Disorder Checklist used by WTC for pre-admission initial assessments.

The Medical Director testified that Austin appeared mildly depressed, but did not show signs of withdrawal, his drug screen was negative for opioids, and Austin denied a history of opioid use. The Medical Director testified that he determined Austin did not exhibit any criteria for an opioid use disorder, and that Austin did not qualify for the medication assisted treatment program.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Williams v. Precision Coil, Inc.
459 S.E.2d 329 (West Virginia Supreme Court, 1995)
Gooch v. West Virginia Department of Public Safety
465 S.E.2d 628 (West Virginia Supreme Court, 1995)
Rand v. Miller
408 S.E.2d 655 (West Virginia Supreme Court, 1991)
Painter v. Peavy
451 S.E.2d 755 (West Virginia Supreme Court, 1994)
Gray v. Mena
625 S.E.2d 326 (West Virginia Supreme Court, 2005)
Joyce E. Minnich v. MedExpress Urgent Care, Inc. - West Virginia
796 S.E.2d 642 (West Virginia Supreme Court, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Nicholas A. Ghaphery, D.O., as Personal Representative of the Estate of Austin Ghaphery v. Wheeling Treatment Center, LLC and John Schultz, M.D., Counsel Stack Legal Research, https://law.counselstack.com/opinion/nicholas-a-ghaphery-do-as-personal-representative-of-the-estate-of-wvactapp-2023.